Search

everythinglearnresearchcommunity

for

Search:↓

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Dutasteride injections can help treat hair loss in men and women.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Nardostachys Jatamansi is an endangered plant with valuable medicinal properties that could lead to safer drug alternatives.

Dutasteride may help shrink prostate cancer tumors.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Some drugs can reduce male semen quality.

Finasteride helps reduce heart enlargement in heart failure patients.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

GI197111X is best dissolved in Capmul MCM for trials.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Strontium ranelate is no longer available for treatment.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

MR antagonists may improve skin health and wound healing, especially in aging.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.